LJPC - La Jolla Pharmaceutical Company

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6161,057-
Cost of Revenue---
Gross Profit6161,057-
Operating Expenses
Research Development62,28829,0929,944
Selling General and Administrative16,70013,93411,396
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-78,372-41,969-21,340
Income from Continuing Operations
Total Other Income/Expenses Net1875727
Earnings Before Interest and Taxes-78,185-41,912-21,313
Interest Expense---
Income Before Tax-78,185-41,912-21,313
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-78,185-41,912-21,313
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-78,185-41,912-21,313
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-78,185-41,912-21,313